SCHEMBL30189228

SCHEMBL30189228

Nc1cc(F)cc2[nH]c(C(=O)O)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF4A3 P38919 2/20 0.54
▸ KDM4E B2RXH2 5/20 0.51
▸ HSD17B10 Q99714 4/20 0.51
▸ HPGD P15428 4/20 0.51
▸ LMNA P02545 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ PDPK1 O15530 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ APEX1 P27695 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ GRIN1 Q05586 3/20 0.47
▸ RHEB Q15382 4/20 0.46
▸ NGFR P08138 1/20 0.44
▸ GRIN2D O15399 2/20 0.43
▸ GRIN3B O60391 2/20 0.43
▸ GRIN2A Q12879 2/20 0.43
▸ GRIN2B Q13224 2/20 0.43
▸ GRIN2C Q14957 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144892 0.84 EIF4A3 (0.63) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL29655546 0.84 EIF4A3 (0.63) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL28926116 0.81 ULK1 (0.50) EIF4A3KDM4EHSD17B10HPGDALDH1A1
SCHEMBL29974385 0.79 GRIN1 (0.70) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL15515831 0.79 GRIN1 (0.70) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL21624049 0.79 KDM4E (0.51) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL29974750 0.79 EIF4A3 (0.54) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL20505503 0.79 EIF4A3 (0.54) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL22395014 0.77 EIF4A3 (0.51) EIF4A3KDM4EHSD17B10HPGDLMNA
SCHEMBL22394978 0.77 EIF4A3 (0.51) EIF4A3KDM4EHSD17B10HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 — — EP disclosed
Send feedback